EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Risk factors for infection in patients with a failed kidney allograft on immunosuppressive medications

Lauren Ogawa, Omer E Beaird, Joanna M Schaenman

Frontiers in Nephrology · 21.08.2023 · 3

DOI: 10.3389/fneph.2023.1149116 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Nephrology, online erschienen am 21.08.2023. Verfasst von Lauren Ogawa und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, David Geffen School of Medicine at University of California-Los Angeles, Los Angeles, CA, United States. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with a failing kidney allograft are often continued on immunosuppression (IS) to preserve residual kidney function and prevent allosensitization. It has been previously accepted that maintaining patients on immunosuppressive therapy results in an increased risk of infection, hospitalization, and mortality. However, as the management of IS in patients with a failed kidney allograft continues to evolve, it is important to review the data regarding associations between infection and specific immunosuppression regimens. We present a review of the literature of failed kidney allograft management and infection risk, and discuss practices for infection prevention. Fifteen studies, published from 1995 to 2022, which investigated the experience of patients with failed allograft and infection, were identified. Infection was most commonly documented as a general event, but when specified, included infections caused by Candida , Mycobacterium tuberculosis , and Aspergillus. In addition, the definition of reduced “IS” varied from decreased doses of a triple drug regimen to monotherapy, whereas others did not specify which medications patients were receiving. Despite attempts at lowering net immunosuppression, patients with failed allografts remain at risk of acquiring opportunistic and non-opportunistic infections. Although opportunistic infections secondary to IS are expected, somewhat surprisingly, it appears that the greatest risk of infection may be related to complications of dialysis. Therefore, mitigating strategies, such as planning for an arteriovenous (AV) fistula over a hemodialysis catheter placement, may reduce infection risk. Additional studies are needed to provide more information regarding the types and timing of infection in the setting of a failed kidney allograft. In addition, more data are needed regarding specific medications, doses, and timing of taper of IS to guide future patient management and inform strategies for infection surveillance and prophylaxis.

Schlagwörter

Stichwörter der Autor:innen

allograft failuredialysisimmunosuppressioninfectionkidney transplantation

Autor:innen und Institutionen

  • Division of Infectious Diseases, David Geffen School of Medicine at University of California-Los Angeles, Los Angeles, CA, United States.

Zitieren

APA

Ogawa, L., Beaird, O. E., & Schaenman, J. M. (2023). Risk factors for infection in patients with a failed kidney allograft on immunosuppressive medications. Frontiers in Nephrology, 3. https://doi.org/10.3389/fneph.2023.1149116

Vancouver

Ogawa L, Beaird OE, Schaenman JM. Risk factors for infection in patients with a failed kidney allograft on immunosuppressive medications. Frontiers in Nephrology. 2023;3. doi:10.3389/fneph.2023.1149116

BibTeX
@article{Ogawa2023,
  author = {Ogawa, Lauren and Beaird, Omer E and Schaenman, Joanna M},
  title = {Risk factors for infection in patients with a failed kidney allograft on immunosuppressive medications},
  journal = {Frontiers in Nephrology},
  year = {2023},
  volume = {3},
  doi = {10.3389/fneph.2023.1149116}
}
Kostenlos starten →